Product Information

KAITLIB FE 0.8-0.025 MG CHEW TB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.4593 per EA under NDC 68180090373. Its NADAC has been published 288 times since May 12, 2021.

FDA first approved this application on Dec 17, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

KAITLIB FE 0.8-0.025 MG CHEW TB

norethindrone and ethinyl estradiol
$1.4593per EA

NDC

68180090373

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203448

FDA Approved

12/17/2015

TE Code

AB

On Market Since

2/7/2021

Price Statistics

The NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has been published 288 times since May 12, 2021, and over the history we have for it it has declined 35.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4593 per EA
All-time high$2.6953 (Oct 13, 2021)
All-time low$0.9745 (Feb 21, 2024)
52-week high$1.8102
52-week low$1.2570
Median price$1.7110
Average price$1.6564
Largest weekly change+54.1% (Sep 22, 2021)
Weeks tracked288
Tracking sinceMay 12, 2021

Price History

1W

0.0%

1M

+4.0%

3M

+16.1%

6M

+10.1%

1Y

-18.2%

3Y

+24.9%

5Y

-43.6%

All

-35.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 87% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KAITLIB FE 0.8-0.025 MG CHEW TB?

The current National Average Drug Acquisition Cost (NADAC) for KAITLIB FE 0.8-0.025 MG CHEW TB, manufactured by Lupin Pharmaceuticals Inc., is $1.4593 per EA (NDC 68180090373), effective Nov 11, 2026.

How has the price of KAITLIB FE 0.8-0.025 MG CHEW TB changed over time?

Over the history we have for it, the NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has declined 35.1%. It has been tracked across 288 weekly CMS publications since May 12, 2021.

What are the highest and lowest recorded NADAC prices for KAITLIB FE 0.8-0.025 MG CHEW TB?

Since May 12, 2021, the NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has ranged from a low of $0.9745 (Feb 21, 2024) to a high of $2.6953 (Oct 13, 2021), with a median of $1.7110 per EA.

Are there cheaper alternatives to KAITLIB FE 0.8-0.025 MG CHEW TB?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYACEN 1-35 28 TABLET, is $0.1936 per EA — about 87% below KAITLIB FE 0.8-0.025 MG CHEW TB.

Who manufactures KAITLIB FE 0.8-0.025 MG CHEW TB?

KAITLIB FE 0.8-0.025 MG CHEW TB (NDC 68180090373) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.